New pill shows promise for advanced eye cancer
NCT ID NCT07136181
First seen Nov 01, 2025 · Last updated Jun 06, 2026 · Updated 27 times
Summary
This study tests an experimental drug, NBM-BMX, in people with metastatic uveal melanoma—a rare eye cancer that has spread to other organs. The goal is to find the best dose, check side effects, and see if the drug can shrink tumors or slow the disease. Participants take the drug as a capsule twice daily and visit the clinic regularly for check-ups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA, METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Honor Health Resarch Institute
RECRUITINGScottsdale, Arizona, 85258, United States
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location
RECRUITINGDenver, Colorado, 80218, United States
Conditions
Explore the condition pages connected to this study.